Genocea finds new malaria biomarker

Genocea Profiles T cell Responses to Identify Antigens Associated with Malaria Episodes Findings reveal evidence of malaria in immune system years after clinical episodes November 5, 2014 Genocea Biosciences, Inc., a company developing T cell-directed vaccines and immunotherapies, today presented study results identifying a cluster of antigens that may be a biomarker of disease. The findings, generated using Genocea’s proprietary …

The New England Journal of Medicine Publishes Results of Final Landmark Phase III Efficacy Clinical Study of Sanofi Pasteur’s Dengue Vaccine Candidate

Study successfully met primary objective and confirms high efficacy against severe dengue and hospitalization Sanofi Pasteur intends to file for registration in several endemic countries in 2015 Dengue vaccine candidate would address an urgent unmet medical need in tropical and sub-tropical regions of the world November 3, 2014 Sanofi Pasteur, the vaccines division of Sanofi, today announced the publication of …